Veery Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$429K Buy
1,691
+335
+25% +$78.1K 0.12% 57
2026
Q1
$331K Sell
1,356
-88
-6% -$20.5K 0.1% 59
2025
Q4
$299K Buy
1,444
+121
+9% +$23.9K 0.09% 66
2025
Q3
$245K Sell
1,323
-9
-0.7% -$1.54K 0.08% 78
2025
Q2
$203K Sell
1,332
-122
-8% -$18.8K 0.07% 93
2025
Q1
$241K Buy
+1,454
New +$228K 0.09% 72
2024
Q4
Sell
-1,235
Closed -$200K 95
2024
Q3
$200K Sell
1,235
-967
-44% -$154K 0.08% 92
2024
Q2
$322K Sell
2,202
-83
-4% -$12.3K 0.13% 68
2024
Q1
$361K Buy
2,285
+42
+2% +$6.68K 0.15% 67
2023
Q4
$352K Sell
2,243
-151
-6% -$23.2K 0.16% 66
2023
Q3
$373K Buy
2,394
+53
+2% +$8.74K 0.18% 61
2023
Q2
$387K Buy
2,341
+156
+7% +$25.2K 0.18% 57
2023
Q1
$339K Sell
2,185
-2
-0.1% -$323 0.18% 56
2022
Q4
$386K Sell
2,187
-963
-31% -$166K 0.23% 47
2022
Q3
$515K Sell
3,150
-35
-1% -$5.92K 0.33% 37
2022
Q2
$565K Buy
+3,185
New +$567K 0.35% 37

Other funds holding JNJ

Veery Capital's JNJ Position: Q2 2026 in Review

Veery Capital increased its Johnson & Johnson (JNJ) stake by 25% in Q2 2026, buying an estimated $78.1K and bringing the position to 1,691 shares worth $429K. The position accounts for 0.12% of the portfolio, ranked #57.

Veery Capital first reported a position in JNJ in Q2 2022 and has held it in 16 quarters since. The position peaked at $565K in Q2 2022. 899 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Veery Capital held 1,691 shares of Johnson & Johnson worth $429K as of Q2 2026.
  • Veery Capital bought 335 Johnson & Johnson shares in Q2 2026, an estimated $78.1K.
  • Johnson & Johnson made up 0.12% of Veery Capital's portfolio in Q2 2026, its #57 holding.
  • Veery Capital first reported a position in Johnson & Johnson in Q2 2022 and has held it in 16 quarters since.
  • Veery Capital's Johnson & Johnson position peaked at $565K in Q2 2022.
  • 899 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Veery Capital's 13F filing for Q2 2026, filed 9 Jul 2026.